cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Curevac
31 own
10 watching
Current Price
$2.44
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,964.77M
52-Week High
52-Week High
12.36000
52-Week Low
52-Week Low
2.36000
Average Volume
Average Volume
0.79M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,964.77M
icon52-Week High12.36000
icon52-Week Low2.36000
iconAverage Volume0.79M
iconDividend Yield--
iconP/E Ratio--
What does the Curevac do?
We are a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid that has the potential to improve the lives of people. Our vision is to revolutionize medicine and open new avenues for developing therapies by enabling the body to make its own drugs. --- Our principal executive offices are located at Friedrich-Miescher-Strasse 15, 72076 Tübingen, Germany. Our telephone number at this address is +49 7071 98830. Our principal website is www.curevac.com.
Read More
News & Events about Curevac.
TheStreet.com
10 months ago
Jon and Pete Najarian join forces to discuss and debate their favorite topics, including the hottest stock-specific news and sports!Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Rivian adopting Tesla's charging standard, Lilly's plans to acquire DICE ...
Accesswire
10 months ago
TÜBINGEN, GERMANY and BOSTON, USA / ACCESSWIRE / June 19, 2023 / CureVac N.V. (Nasdaq:CVAC), a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), today announced the voting results of...
Accesswire
1 year ago
TÜBINGEN, GERMANY / BOSTON, MA / ACCESSWIRE / February 7, 2023 / CureVac N.V. (NASDAQ:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), announced today that it intends...
Accesswire
1 year ago
CureVac recognized as a Top 100 innovator in acknowledgment of the company's innovative strength and extensive intellectual property portfolioThe company holds one of broadest intellectual property portfolios in mRNA technologyTÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / January 31...
Frequently Asked Questions
Frequently Asked Questions
What is Curevac share price today?
plus_minus_icon
Can Indians buy Curevac shares?
plus_minus_icon
How can I buy Curevac shares from India?
plus_minus_icon
Can Fractional shares of Curevac be purchased?
plus_minus_icon
What are the documents required to start investing in Curevac stocks?
plus_minus_icon
What is today’s traded volume of Curevac?
plus_minus_icon
What is today’s market capitalisation of Curevac?
plus_minus_icon
What is the 52-Week High and Low Range of Curevac?
plus_minus_icon
What percentage is Curevac down from its 52-Week High?
plus_minus_icon
What percentage is Curevac up from its 52-Week Low?
plus_minus_icon
Current Price
$2.44
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00